ELVNEnliven Therapeutics, Inc.

$59.35

Is it safe?

Can ELVN take a bad year?

The deepest fall in ELVN's price history on file is −98%; it is 2.9% below its high today.

−98%

Worst drawdown on file · −2.9% today

Cash runway
5+ years

Cash runway · burning $17M a quarter at the current rate

Annualised volatility
72%

Annualised volatility · three times the market's own swing

Details
Cash and short-term investments
$895M
EBITDA, trailing twelve months
−$124M
Operating profit, trailing twelve months
−$124M
Annualised volatilitytwo years of daily moves
72%
Worst drawdown on file
−98%
Below its 52-week high
2.9%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.